Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

15 results about "Hirsutism" patented technology

Unwanted, excessive hair growth in women either on face, chest or back.

Methods and compositions for treating polycystic ovary syndrome

PCT designated stage expiredWO2025038392A1Organic active ingredientsPharmaceutical non-active ingredientsPhysiologyIncreased androgen level
Polycystic ovary syndrome (PCOS) is characterized by elevated levels of androgens, cysts in the ovaries, and irregular periods. Women with PCOS present with additional symptoms, including hirsutism, alopecia, acne, infertility, weight gain, fatigue, depression and mood changes. The present disclosure provides new compounds, salts, compositions and uses thereof in the treatment of PCOS due to elevated adrenal androgens. Further, the present disclosure provides methods for treating PCOS due to elevated adrenal androgens.
Owner:SPRUCE BIOSCIENCES INC

Treatment of hirsutism, polycystic ovary syndrome and other related conditions

PendingCN122297484APhysiologyEstradiolum
Treatment of hirsutism, polycystic ovary syndrome, and other related conditions. This invention relates to a novel treatment for hirsutism, wherein a combination of dinogest and ethinylestradiol is administered to the subject in need.
Owner:CHEMO RESEARCH LTD

Clascoterone formulations and methods of use thereof

PCT designated stageWO2026087531A1Organic active ingredientsAerosol deliveryFemale pattern alopeciaEczematous rash
The present disclosure is related to a topical formulation comprising clascoterone in a mixture of aqueous and oily gel phases. The present disclosure further relates to a method of treating or preventing skin conditions such acne vulgaris, acne conglobata, acne fulminans, androgenetic alopecia, hidradenitis suppurativa (also known as acne inversa), hirsutism, cancer-therapy-induced rash, eczema, rosacea, atopic dermatitis, psoriasis, inverse psoriasis, seborrheic dermatitis, acanthosis nigricans, wound, and female pattern hair loss, comprising topically administering to a subject in need thereof an effective amount of the formulation.
Owner:CASSIOPEA SPA

Traditional Chinese medicine composition for treating alopecia areata as well as preparation method and application thereof

The invention provides a traditional Chinese medicine composition for treating alopecia areata and a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicine preparations. The traditional Chinese medicine composition is prepared from the following components in parts by mass: 10 to 30 parts of radix rehmanniae recen, 10 to 30 parts of radix rehmanniae preparata, 10 to 30 parts of caulis spatholobi, 10 to 30 parts of caulis polygoni multiflori, 30 to 50 parts of radix astragali, 10 to 20 parts of rhizoma chuanxiong, 10 to 30 parts of radix paeoniae alba, 5 to 20 parts of rhizoma gastrodiae, 5 to 20 parts of cordyceps sinensis, 10 to 30 parts of herba ecliptae, 10 to 30 parts of mulberry and 5 to 20 parts of fructus chaenomelis. The effect is stronger, and no side effect exists. The tincture prepared by the invention is a pure external preparation without systemic toxicity, has no side effects such as hirsutism and skin atrophy after long-term use, and is especially suitable for sensitive scalp patients.
Owner:JIANGXI SCI & TECH NORMAL UNIV

Use of a composition for the preparation of a medicament for the prevention and treatment of polycystic ovary syndrome

PendingCN122499271APhysiologyPhosphorylation
This invention belongs to the field of biomedical technology, specifically relating to the application of a composition in the preparation of a drug for the prevention and treatment of polycystic ovary syndrome (PCOS). The composition comprises bovine spleen peptide and adenosine; the mass ratio of bovine spleen peptide to adenosine is 1:(1-2.5). Bovine spleen peptide, as a bioactive polypeptide, significantly improves insulin resistance associated with PCOS by targeting and activating the PI3K-Akt signaling pathway and promoting insulin receptor substrate phosphorylation. Adenosine, as a natural bioactive substance, significantly reduces serum luteinizing hormone and testosterone levels in rats and increases follicle-stimulating hormone levels, thereby effectively alleviating hyperandrogenism symptoms such as hirsutism and acne in PCOS. Furthermore, this composition can significantly improve polycystic pathological changes in the ovarian tissue of model rats, reduce the number of cystic dilated follicles, restore the granulosa cell layer structure, alleviate ovarian stromal hyperplasia, and promote normal follicular development.
Owner:HUANGHUAI UNIV

Topical composition comprising prostaglandin analogue

To provide a topical composition useful for the treatment of hair disorders such as androgenetic alopecia, hirsutism, alopecia of the eyebrow and eyelashes, and hypotrichosis.SOLUTION: Provided is a composition for topical treatment of diseases or conditions affecting the pilosebaceous unit or its components, the composition comprising a prostaglandin analogue as an active ingredient, and further comprising a co-solvent and a semi-fluorinated alkane.SELECTED DRAWING: None
Owner:DERMALIQ THERAPEUTICS INC

Bridged ring compound and application thereof

The invention discloses a bridged ring compound shown as a formula I, or an isotope compound of the bridged ring compound, or a pharmaceutically acceptable salt # imgabs0 # of the bridged ring compound. The bridged ring compound, or the isotope compound thereof, or the pharmaceutically acceptable salt thereof has appropriate pharmacokinetic properties, is beneficial to patent medicine, has excellent antagonism / inhibition effects on androgen receptor and androgen receptor antagonist-resistant prostate cancer cells, and can be used for preparing drugs for prostate cancer. The traditional Chinese medicine composition can be prepared into medicines for treating diseases such as prostatic cancer, benign prostatic hypertrophy, male hair loss, muscle reduction, hirsutism and the like, is wide in application and has a good market prospect.
Owner:CHINA PHARM UNIV

Sprayable liquid spironolactone compositions

PCT designated stage expiredWO2024206615A3Pharmaceutical non-active ingredientsSheet deliveryFemale pattern alopeciaHidradenitis
The present disclosure provides a sprayable liquid composition comprising about 1% w / v to about 20% w / v spironolactone or canrenone, about 30% w / v to about 97% w / v aliphatic solvent, about 1% w / v to about 10% w / v water, one or more film forming excipients, wherein the film forming excipient has a solubility in water at a pH between 1 and 10, and a penetration enhancer, wherein the composition forms a washable and / or a peelable film when sprayed on a skin surface, and wherein the spironolactone does not crystallize when the composition is applied to the skin surface. The disclosure also provides a method of treating acne, male and female pattern hair loss, hirsutism, hidradenitis suppurativa, polycystic ovary syndrome (PCOS), or combinations thereof in a subject in need thereof, the method comprising topically applying the composition described herein as a spray to a skin surface of the subject.
Owner:CELISTA PHARMACEUTICALS LLC

Extract enriched in unsaturated fatty acids from the processing waste of food products based on wild strawberries and / or garden strawberries

Extract enriched in unsaturated fatty acids from processing waste in the production of foods based on Fragaria vesca (wild strawberry) and / or Fragaria x ananassa (strawberry or garden strawberry) obtained by supercritical extraction in CO2, characterised by the fact that it has a peroxide content less than 60 meq / kg of extract, related preparation process, related compositions in particular for cosmetic use. This extract can be used for the treatment and prevention of disorders of inflammatory origin, such as atopic dermatitis and psoriasis, and / or it can be used for the treatment of skin and hair disorders associated with hormonal imbalance, for example overproduction of dihydrotestosterone, such as acne vulgaris, hirsutism, seborrhoea, telogen effluvium and androgenic alopecia, or it can be used as an emollient and / or humectant to restore the moisture of the barrier layer.
Owner:UNIFARCO SPA

Skin treatment device

ActiveCN309038192SSkin treatmentsPhysiology
1. The name of the product under this design: skin treatment device. 2. Purpose of the product of this design: used for the treatment of hirsutism (hair removal) and skin rejuvenation. 3. The design key point of this appearance design product lies in the shape. 4. The picture or photo that best illustrates the design points: Stereoscopic diagram 1.
Owner:SHENZHEN LEAFLIFE TECH CO LTD

Hair management device (Martian)

ActiveCN310090901SBiotechnologyAnimal science
1. Name of the product in this design: Hair Management Device (Martian). 2. Purpose of this design: This design is for hair management, primarily targeting the treatment of hirsutism. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: a 3D model.
Owner:孙飞龙

NEW ANALOGUES AS REGULATORS OF ANDROGONE RECEPTORS AND GLUCOCORTICOD RECEPTORS

UndeterminedCY1125964T1DiseasePsychosis drug
The present invention relates to novel dihydropyridine derivatives of the chemical formula (I) as modulators of nuclear receptors selected from androgen and glucocorticoid receptors, to a process for their preparation, to pharmaceutical compositions containing said compounds and to the use of said compounds for the manufacture of pharmaceutical preparations for the treatment of pathological conditions or diseases that can be improved by modulating the androgen receptor and / or the glucocorticoid receptor, selected from cancer, metastatic cancer, benign prostatic hyperplasia, polycystic ovary syndrome (PCOS), hair loss, hirsutism, acne, hypogonadism, muscle-wasting diseases, cachexia, Cushing's syndrome, weight gain induced by antipsychotic drugs, post-traumatic stress disorder and alcoholism.
Owner:ONCOSTELLAE SL

Methods and compositions for treating polycystic ovarian syndrome

PendingCN118948857AOrganic chemistrySexual disorderPhysiologyIncreased androgen level
Polycystic ovarian syndrome (PCOS) is characterized by elevated androgen levels, ovarian cysts and irregular menstruation. Female with PCOS may have additional symptoms, including hirsutism, alopecia, acne, infertility, weight gain, fatigue, depression, and emotional changes. The present disclosure provides novel compounds, salts, compositions and their use in the treatment of PCOS due to elevated adrenal androgen. In addition, the present disclosure provides methods for treating PCOS due to elevated adrenal androgen.
Owner:SPRUCE BIOSCIENCES INC

Compositions and methods for inhibiting hair growth

InactiveUS20250049683A1Organic active ingredientsCosmetic preparationsProstaglandin analogFP receptor
A method for inhibiting hair growth in mammals using compositions containing FP receptor antagonists (e.g., prostaglandin F analogs that are block activation of the FP receptor). The compositions can be applied topically to the skin and / or hair. The compositions can arrest hirsutism or hypertrichosis, reverse hirsutism and hypertrichosis, and further prevent hair growth. These compositions can also be used to protect hair from chemical or radiation-induced alopecia or hair loss. These compositions can also be used to inhibit pigmentation of the hair or skin.
Owner:OLSEN ELISE A